arrow
O

Oscar L. López

Erasmus MC
H指数:123
被引数:6.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Astrocyte reactivity identifies p-tau217-positive individuals at elevated risk of cognitive decline across the Alzheimer’s disease continuum

星形胶质细胞反应性识别阿尔茨海默病连续谱中p-tau217阳性个体认知下降的高风险

2026-09-210
OAAI
Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer’s disease

简化的资源高效的血浆淀粉样蛋白-β 质谱测定改善了临床前阿尔茨海默氏病的生物标志物性能

2026-01-220
OAAI
Corrigendum to “Where do plasma biomarkers fit in with current Alzheimer’s disease detection?” [volume 33, issue 4, April 2025, pages 428–437]

勘误:“Where do plasma biomarkers fit in with current Alzheimer’s disease detection?” [卷33,期4,2025年4月,页码428–437]

2025-06-270
OAAI
An inverse association of cerebral amyloid-β deposition and serum docosahexaenoic acid levels in cognitively normal older adults in Japan

日本认知正常老年人中脑内淀粉样蛋白-β沉积与血清二十二碳六烯酸水平呈负相关

2025-05-080
PRE
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing

通过全基因组测序破译ftld-tdp病理亚型的不同遗传危险因素

2025-04-250
OA
Circulating non-esterified fatty acids, risk of dementia and cognitive decline: The cardiovascular health study and multi-ethnic study of atherosclerosis
2025-04-010
PRE
Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain study

中老年心血管风险与阿尔茨海默病生物标志物、神经退行性变及白质高信号的相关性:Heart SCORE脑部研究

2025-01-150
OA
Head‐to‐head comparison of four different plasma p‐tau217 assays to detect brain amyloid pathology and cognitive decline in diverse population‐based cohorts

四种不同血浆p-tau217检测方法的头对头比较:在基于人群的不同队列中检测脑淀粉样蛋白病理和认知下降

2025-01-090
OA
Exploring the utility of Plasma GFAP as a secondary endpoint in Alzheimer's disease Clinical trials to monitor disease progression

探索血浆GFAP作为阿尔茨海默病临床试验中监测疾病进展的次要终点指标的应用价值

2025-01-090
OA
A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies

在10项队列研究中开发和验证的最常见衰老疾病的单一风险评估

2024-10-310
OAAI